Home/Fulgent Genetics/Kathy L. Valentine
KL

Kathy L. Valentine

Chief Legal Officer and Corporate Secretary

Fulgent Genetics

Fulgent Genetics Pipeline

DrugIndicationPhase
Nanoencapsulation & Targeted Therapy PlatformBroad range of cancersPre-clinical